Companies: 49,302 Total Market Cap: 131116972256484.56

Smith & Nephew plc

NYSE: SNN
Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Rank #1518
Market Cap 12.55 B
Volume 948,581
Price 28.63
Change (%) 0.81%
Country or region United Kingdom United Kingdom

Smith & Nephew plc's latest marketcap:

12.55 B

As of 05/25/2025, Smith & Nephew plc's market capitalization has reached $12.55 B. According to our data, Smith & Nephew plc is the 1518th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 12.55 B
Revenue (ttm) 5.81 B
Net Income (ttm) 412 M
Shares Out 873.49 M
EPS (ttm) 0.47
Forward PE 0.00
Ex-Dividend Date 03/28/2025
Earnings Date 02/25/2025
Market Cap Chart
Data Updated: 05/25/2025

Smith & Nephew plc's yearly market capitalization.

Smith & Nephew plc has seen its market value drop from $13.22 B to $12.55 B since 2020, representing a total decrease of 5.00% and an annual compound decline rate (CAGR) of 1.16%.
Date Market Cap Change (%)
05/25/2025 $12.55 B 0.34%
12/31/2024 $8.65 B -7.88%
12/29/2023 $9.39 B -2.72%
12/30/2022 $9.65 B -15.11%
12/31/2021 $11.36 B -14.01%
12/31/2020 $13.22 B

Company Profile

About Smith & Nephew plc

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services globally, with operations in the UK, the US, and other international markets.

Business Segments

  • Orthopaedics: Offers knee and hip implants, trauma and extremities products, and other reconstruction solutions.
  • Sports Medicine & ENT: Provides joint repair products, arthroscopic enabling technologies, and ear, nose, and throat solutions.
  • Advanced Wound Management: Delivers wound care products, bioactives, regenerative medicine, and wound therapy devices.

Key Products & Services

  • Knee and hip replacement implants.
  • Sports medicine solutions for soft tissue injuries and degenerative conditions.
  • Advanced wound care for acute and chronic wounds, ulcers, and burns.
  • Regenerative medicine products, including skin and bone graft substitutes.
  • Negative pressure wound therapy and hydrosurgery systems.

The company serves healthcare providers and was founded in 1856, with its headquarters located in Watford, UK.

Frequently Asked Questions

As of 05/25/2025, Smith & Nephew plc (including the parent company, if applicable) has an estimated market capitalization of $12.55 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Smith & Nephew plc global market capitalization ranking is approximately 1518 as of 05/25/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region United Kingdom
Founded 1856
IPO Date n/a
Employees 18,060
CEO Deepak Nath
Sector
Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Address Building 5
Watford, WD18 8YE
United Kingdom
Website https://www.smith-nephew.com